Abstract:
Objective Herpetic angina is a common acute infectious disease mainly occurring in children aged 1 to 7 years. The clinical manifestations are mucosal herpes, fever, ulcer and other symptoms, which seriously threaten the health of children. The purpose of this study was to investigate the clinical effect of Anerning granule combined with ribavirin in the treatment of children with herpetic angina.
Methods 84 children with herpetic angina treated in our hospital from January to December 2023 were selected as the study objects, and were divided into control group and observation group according to random number table method, with 42 cases in each group. The control group was treated with ribavirin alone, and the observation group was treated with Anerning granule combined with the control group for 7 days. The clinical efficacy, improvement of clinical symptoms and humoral immunity indexes of the two groups were compared.
Results After treatment, the total effective rate of the observation group was higher than that of the control group, the scores of clinical symptoms were lower than that of the control group, and the humoral immunity was higher than that of the control group, with statistical significance (P<0.05).
Conclusion Anerning Granule combined with ribavirin in the treatment of children with herpetic angina can effectively relieve clinical symptoms, regulate immunity, and have better curative effect.
Keywords: Herpetic angina in children; Anerning granules; Ribavirin; Clinical observation; Humoral immunity
